S2 Genomics, Inc., a leader in single-cell genomics and cell biology applications, is thrilled to announce its new distribution agreement with Bonsailab. This agreement enables the promotion, sale, and support of the Singulator™ 100 and 200 systems and associated products in Spain and Portugal. Now, researchers in these countries have access to cutting-edge single-cell genomics technology at their fingertips.
S2 Genomics and Bonsailab have partnered to provide their customers with improved, automated tissue dissociation solutions for single-cell applications. This strategic partnership is part of S2 Genomics’ larger mission to create a global supply chain of value-added solutions for single-cell customers. The Iberian Peninsula is at the forefront of this rapid growth in single cell genomics and cell biology, and S2 Genomics’ Vice President of Global Channel Sales, Dr. Ravi Vinayak, is thrilled to witness the expansion of this network. CEO Dr. Stevan Jovanovich is equally excited, and looks forward to the positive impact this partnership will have on single-cell research.
S2 Genomics’ Singulator™ 100 and Singulator™ 200 systems are revolutionizing the way solid tissue samples are isolated into single-cells or nuclei. These revolutionary systems provide state-of-the-art automation and convenience, with single-use disposable cartridges and proprietary reagents. Plus, users can customize their own dissociation protocols and use their own reagents to create maximum flexibility. Best of all, the low-temperature dissociation process allows users to get high-quality single-cell data without compromising cell transcriptomes.
Rafael Calderon, General Manager of Bonsailab, couldn’t be more excited to join forces with S2 Genomics and bring the Singulator systems to the market, greatly expanding their product portfolio for single cell genomics and cell biology applications. With the Singulator, customers can now benefit from streamlined workflows for a wide range of sample types and applications, including clinical research.
About S2 Genomics, Inc.
Unlock the power of single-cell sequencing with S2 Genomics! Founded in 2016, S2 Genomics is a leading developer of laboratory automation solutions that integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for single-cell sequencing and cell biology applications. Our technology platforms are revolutionizing life science research, healthcare, and agriculture, enabling new discoveries and innovations. Experience the power of S2 Genomics today – for Research Use Only, not for use in diagnostic procedures.